Boston, MA -- (SBWIRE) -- 08/30/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (McDermott International (NYSE:MDR), Coeur d'Alene Mines Corporation (NYSE:CDE), Forest Oil Corporation (NYSE:FST), Inovio Pharmaceuticals Inc (NYSEMKT:INO)
McDermott International (NYSE:MDR) shares increased 0.13% to $7.65. Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor, LLP on August 28 announce that a federal class action lawsuit has been filed against McDermott International, Inc. ("McDermott" or "Company") (NYSE: MDR) and several of its officers and directors for acts taken during the period of November 6, 2012 to August 5, 2013 (the "Class Period").
Additionally, the company issued its quarterly earnings data on August 6. The company reported ($0.63) earnings per share for the quarter, missing the analysts’ consensus estimate of $0.03 by $0.66. The company had revenue of $647.25 million for the quarter, compared to the consensus estimate of $757.87 million.
Is MDR A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Coeur d'Alene Mines Corporation (NYSE:CDE) shares decreased 2.14% to $14.63. The company on August 8 reported metal sales of $204.5 million, cash flow from operating activities of $63.3 million, or $0.63 per share, and capital expenditures of $27.2 million during the second quarter 2013. The Company produced 4.6 million ounces of silver and 60,757 ounces of gold during the second quarter 2013, representing increases of 21% and 7%, respectively, over the first quarter 2013. Silver and gold production at the Palmarejo mine in Mexico increased 24% and 23%, respectively, compared to the first quarter.
Is CDE A Good Buy After The Recent Price Movement? Find Out Here
Forest Oil Corporation (NYSE:FST) shares fell 2.85% to $5.46. The company on August 6 said it swung to a second-quarter profit on fewer charges. The company reported a profit of $33.4 million, or 28 cents a share, compared with a year-ago loss of $511.2 million, or $4.44 a share. Adjusted per-share earnings were flat at six cents a share. Revenue declined 14% to $116.8 million. Analysts were expecting earnings of a penny a share on revenue of $120 million.
How Should Investors Trade FST After The Recent Volatility? Get Free Report Here
Inovio Pharmaceuticals Inc (NYSEMKT:INO) shares increased 3.64% to $1.71. The company on August 15 announced that its SynCon® DNA vaccine containing multiple malaria antigens delivered via its CELLECTRA® electroporation device demonstrated strong and durable antibody and T-cell immune responses in small animals and non-human primates. With these strong preclinical results, Inovio plans to initiate a phase I/IIa clinical trial next year.
Additionally, the company on August 9 reported second-quarter net loss to common stock of $11 million or $0.06 per share, compared with $4 million or $0.03 per share last year. Revenues for the quarter were $0.8 million, compared with $0.4 million in the prior year. Analysts estimated a loss of $0.04 per share on revenues of $1.07 million for the quarter.
How Should Investors Trade INO After The Recent Volatility? Get Free Report Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)